EN DE

The Gabelli Healthcare & Wellness Trust (GRX) Fair Value & Analysis

Financial Services · US · Market cap $134M

TG The Gabelli Healthcare & Wellness Trust logo The Gabelli Healthcare & Wellness Trust GRX · US
Price$9.88
Fair Value$2.64
Upside-73.3%
Quality71/100
Watch The Gabelli Healthcare & Wellness Trust for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 0.0% net margin
generates free cash flow
Trails peers (2/11)
Narrow moat 41/100
Evidence: High Range $1.98 – $3.30 Share as image

Fair value as of: Jul 26, 2026

From 12 valuation models · updated 15 days ago

Share price +2.7% over the past month.

A solid business, but screening 73% overvalued on our models.

What matters now

  • A high-quality business (quality 71/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case ($3.30). The favourable scenario is already priced in.
  • For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$10.31 $6.46 Fair Value $2.64 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 26, 2026.

How to read this chart

60‑month range $6.46 – $10.31 · fair‑value band $1.98 – $3.30 · the $9.88 price screens above the $2.64 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 26, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

The Gabelli Healthcare & Wellness Trust (GRX) currently trades at $9.88, while our model-based Fair Value estimate is $2.64, implying the stock looks roughly 73.3% overvalued today. The Quality Score stands at 71/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Net debt stands at $70.7M. The stock trades on a trailing P/E of 59.3. Fundamentals as of Jul 26, 2026

Our scenario range runs from $1.98 (bear case) to $3.30 (bull case); at $9.88, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 19% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -12% fair-value upside, at -73%, GRX screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income $6.74 $6.24 $4.09 76
Growth DCF $7.09 $11.45 $18.26 72
Gordon GGM $4.79 $8.02 $10.40 70
All 12 models by family
DCF Models
5Y P/E Exit $3.67 $6.16 $9.21 38
10Y P/E Exit $5.11 $8.33 $12.87 35
Earnings-Based
Graham-Dodd $1.06 $7.37 $10.34 54
Lynch FV $3.81 $5.44 $7.07 50
Dividend Discount
Gordon GGM $4.79 $8.02 $10.40 70
DDM Multi-Stage $4.79 $7.60 $8.62 61
Multiples
P/E Multiple $1.51 $2.02 $2.52 63
P/B Multiple $1.98 $2.64 $3.30 55
Asset-Based
NCAV (Graham) $5.37 $7.19 $10.73 50
Growth DCF
Growth DCF $7.09 $11.45 $18.26 72
Rev-Margin DCF $3.95 $5.66 $9.24 67
Economic Profit
Residual Income $6.74 $6.24 $4.09 76

Widest divergence: Dividend Discount ($7.60) versus Multiples ($2.02). Highest evidence: Residual Income (76).

Notify me when GRX reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Return on equity -1,374%
Free cash flow $9.4M FY2025
P/E ratio 59.3
EPS (TTM) $0.1500
Net debt $70.7M FY2025

Figures from reported company fundamentals · as of Jul 26, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 71/100

Of which business quality 70 · Market factors (momentum, volatility) 72

Profitability 24
Margins and returns on capital today
Quality Growth 67
Are margins and returns improving?
Cashflow 100
Earnings quality: real cash, not paper profit
Fin. Strength 53
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 52
Price trend over the last 3–12 months (market factor)
52W Momentum 75
Distance to the 52-week high (market factor)
Net Issuance 97
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector.

Full company description

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

The Gabelli Healthcare & Wellness Trust reported revenue of $15.3M in FY2025 versus $43.5M in FY2021, a compound −23.0%/yr. Reported net income was $2.3M in FY2025, compounding −51.9%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$15.3M
Latest YoY
+368.7%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−9.4%
Avg. growth/yr (18Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.7%
Revenue −23.0%/yr
FY21 $43.5M
FY22 −$46.7M
FY23 $4.0M
FY24 $3.3M
FY25 $15.3M
Net income −51.9%/yr
FY21 $42.7M
FY22 −$47.4M
FY23 $423K
FY24 −$285K
FY25 $2.3M

GRX screens 73% overvalued. Compare with Fondul Proprietatea SA →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "The Gabelli Healthcare & Wellness Trust Fair Value". https://www.fairvalue-calculator.com/stock/GRX

Peer Group

Asset Management · 971 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 72 · Top 25%
Fair Value upside −73% · Bottom 25%
Return on assets 0% · Below median
Net margin (TTM) 0% · Below median
Operating margin (TTM) 0% · Bottom 25%
Revenue growth 0% · Below median
Dividend yield (TTM) 0.0% · Bottom 25%

Valuation Multiples vs Asset Management median · lower = cheaper

P/E (TTM) 59.3× · Pricier than 75% of peers
P/B 0.84× · Cheaper than median
P/FCF 14.2× · Pricier than median
EV/EBITDA 28.1× · Pricier than 75% of peers

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 26, 2026).

Stock Price Fair Value vs Fair Value
Fondul Proprietatea SA FP $0.0420 $0.0800 +90%
BlackRock, Inc BLK $1,136 $465.75 -59%
Blackstone Inc BX $124.56 $16.35 -87%
Investor AB INVEB kr 423.70 kr 847.40 +100%
Brookfield Corporation BN C$62.45 C$10.12 -84%
KKR & Co KKR $100.94 $44.88 -56%
AB Industrivärden INDUA kr 532.50 kr 1,065 +100%
Jio Financial Services Limited JIOFIN ₹242.98 ₹40.19 -83%
Hedef Holding HEDEF 267.25 TRY 320.98 TRY +20%
Bajaj Holdings BAJAJHLDNG ₹10,398 ₹9,202 -12%

Compare The Gabelli Healthcare & Wellness Trust with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is The Gabelli Healthcare & Wellness Trust (GRX) overvalued or undervalued?
As of Jul 26, 2026, our model estimates a fair value of $2.64 versus a price of $9.88, about −73% (overvalued).
What is the fair value of GRX?
Our model-based fair value for The Gabelli Healthcare & Wellness Trust is $2.64 (as of Jul 26, 2026), built from audited fundamentals. The current price is $9.88.
What is the quality score of GRX?
The Gabelli Healthcare & Wellness Trust has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the net profit margin of GRX?
The net profit margin of The Gabelli Healthcare & Wellness Trust is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track The Gabelli Healthcare & Wellness Trust and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.